Topical antifungal bigels: Formulation, characterization and evaluation Cover

.blurhash-client-img { display: none !important; }

Topical antifungal bigels: Formulation, characterization and evaluation

Acta Pharmaceutica

Volume 68 (2018): Issue 2 (June 2018)

By: Agne Mazurkeviciute, Kristina Ramanauskiene, Marija Ivaskiene, Aidas Grigonis and Vitalis Briedis

Open Access

|Apr 2018

Authors

Agne Mazurkeviciute

agne.mazurkeviciute@lsmuni.lt

Department of Clinical Pharmacy Faculty of Pharmacy, Lithuanian University of Health Sciences, Kaunas, Lithuania

Kristina Ramanauskiene

Department of Clinical Pharmacy Faculty of Pharmacy, Lithuanian University of Health Sciences, Kaunas, Lithuania

Marija Ivaskiene

Department of Non-infectious Diseases, Faculty of Veterinary Medicine, Veterinary Academy Lithuanian University of Health Science, Kaunas, Lithuania

Aidas Grigonis

Department of Non-infectious Diseases, Faculty of Veterinary Medicine, Veterinary Academy Lithuanian University of Health Science, Kaunas, Lithuania

Vitalis Briedis

Department of Clinical Pharmacy Faculty of Pharmacy, Lithuanian University of Health Sciences, Kaunas, Lithuania

DOI: https://doi.org/10.2478/acph-2018-0014 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 223 - 233

Accepted on: Dec 21, 2017

Published on: Apr 26, 2018

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

ciclopirox olamine,

terbinafine hydrochloride,

Related subjects:

Pharmacy, other

© 2018 Agne Mazurkeviciute, Kristina Ramanauskiene, Marija Ivaskiene, Aidas Grigonis, Vitalis Briedis, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 68 (2018): Issue 2 (June 2018)Next article